Stem cell-derived sensory neurons modelling inherited erythromelalgia: normalization of excitability
Stem cell-derived sensory neurons modelling inherited erythromelalgia: normalization of excitability
复制标题
DOI:
10.1093/brain/awac031
复制
发表时间:
2022-01-28
期刊:
影响因子:
14.5
通讯作者:
Waxman, Stephen G.
中科院分区:
文献类型:
--
作者:
Alsaloum, Matthew;Labau, Julie I. R.;Waxman, Stephen G.
Alsaloum et al. report that the hyperexcitability of human stem cell-derived sensory neurons, made to recapitulate dorsal root ganglion neurons from patients with inherited erythromelalgia via dynamic clamp electrophysiology, can be normalized by precise subtraction of Na(V)1.7 currents.Effective treatment of pain remains an unmet healthcare need that requires new and effective therapeutic approaches. Na(V)1.7 has been genetically and functionally validated as a mediator of pain. Preclinical studies of Na(V)1.7-selective blockers have shown limited success and translation to clinical studies has been limited. The degree of Na(V)1.7 channel blockade necessary to attenuate neuronal excitability and ameliorate pain is an unanswered question important for drug discovery. Here, we utilize dynamic clamp electrophysiology and induced pluripotent stem cell-derived sensory neurons (iPSC-SNs) to answer this question for inherited erythromelalgia, a pain disorder caused by gain-of-function mutations in Na(v)1.7. We show that dynamic clamp can produce hyperexcitability in iPSC-SNs associated with two different inherited erythromelalgia mutations, Na(V)1.7-S241T and Na(V)1.7-I848T. We further show that blockade of approximately 50% of Na(V)1.7 currents can reverse neuronal hyperexcitability to baseline levels.